Literature DB >> 2323844

DNA adducts in different tissues of smokers and non-smokers.

J Cuzick1, M N Routledge, D Jenkins, R C Garner.   

Abstract

Purified DNA from human lung, liver, bladder, pancreas, breast and cervix has been analysed for DNA adducts using the nuclease P1 modification of the 32P post-labelling technique. Tissues were obtained at autopsy from 13 men and 6 women. Relatives were asked to provide information on smoking history for deceased subjects. All tissues examined except the breast had detectable adducts. In lung, bladder and pancreatic tissue a characteristic pattern of adducts was seen which has previously been reported as typical of cigarette-smoke-induced damage. Smokers and former smokers tended to have higher adduct levels than non-smokers in the tissues examined but this was only significant for the lung. There appeared to be considerable variation in adduct levels among smokers which could not be accounted for by duration or daily consumption level. Certain smokers had high adduct levels in all tissues examined, whilst in others high levels were only seen in some tissues. All cervical samples examined had detectable adducts. These results confirm the finding that cigarette smoking is associated with DNA damage in the lung and suggest that similar damage may be related to tobacco-induced neoplasms of other tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323844     DOI: 10.1002/ijc.2910450417

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Viruses and cervical cancer.

Authors:  A Singer; D Jenkins
Journal:  BMJ       Date:  1991-02-02

2.  Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct.

Authors:  G Talaska; A Z al-Juburi; F F Kadlubar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  DNA damage in the stomach after vagotomy measured by 32P-postlabelling.

Authors:  G W Dyke; J L Craven; R Hall; R C Garner
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

4.  Molecular cancer epidemiology can predict risk.

Authors:  R C Garner; K Dingley; C M Dale
Journal:  BMJ       Date:  1995-01-14

5.  Cigarette smoking and cervical cancer.

Authors:  J Eluf-Neto
Journal:  BMJ       Date:  1993-08-07

6.  Neighborhood socioeconomic status modifies the association between individual smoking status and PAH-DNA adduct levels in prostate tissue.

Authors:  Andrew Rundle; Catherine Richards; Christine Neslund-Dudas; Deliang Tang; Benjamin A Rybicki
Journal:  Environ Mol Mutagen       Date:  2012-03-29       Impact factor: 3.216

7.  CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.

Authors:  Carmen San Jose; Agustin Cabanillas; Julio Benitez; Juan Antonio Carrillo; Mercedes Jimenez; Guillermo Gervasini
Journal:  BMC Cancer       Date:  2010-08-30       Impact factor: 4.430

Review 8.  The analysis of DNA adducts: the transition from (32)P-postlabeling to mass spectrometry.

Authors:  Joshua J Klaene; Vaneet K Sharma; James Glick; Paul Vouros
Journal:  Cancer Lett       Date:  2012-09-04       Impact factor: 8.679

9.  Urinary excretion of mutagens and covalent DNA damage induced in the bladder and kidney after passive smoking in rats.

Authors:  J Takenawa; Y Kaneko; K Okumura; H Nakayama; J Fujita; O Yoshida
Journal:  Urol Res       Date:  1994

10.  Damage to DNA in cervical epithelium related to smoking tobacco.

Authors:  A M Simons; D H Phillips; D V Coleman
Journal:  BMJ       Date:  1993-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.